
    
The genomic variant c.1654G>T p.Gly552Cys rs1201448391 in the ALOX12B gene is a missense mutation that results in the substitution of glycine with cysteine at the 552nd amino acid position of the protein. This variant has been identified in the context of hereditary ichthyosis, a clinically and genetically heterogeneous disorder. The ALOX12B gene encodes the 12R-lipoxygenase enzyme, which is crucial for the proper functioning of the epidermal barrier. Deficiencies or disruptions in the enzyme's activity due to mutations such as c.1654G>T can lead to abnormal barrier function, which is a characteristic feature of certain types of ichthyosis, including congenital ichthyosiform erythroderma (CIE) [1][2].The c.1654G>T variant has been classified as pathogenic/likely pathogenic according to the American College of Medical Genetics and Genomics (ACMG) criteria, which underscores its clinical significance in the diagnosis of hereditary ichthyosis. Whole exome sequencing (WES) has proven to be a powerful tool in identifying such mutations, enabling accurate molecular diagnosis and facilitating reproductive planning, carrier screening, and prenatal diagnosis for at-risk families [1]. The identification of this variant contributes to the growing body of evidence that supports the diagnostic value of WES in hereditary ichthyosis and highlights the importance of genetic testing in the management and counseling of affected individuals and their relatives.

ALOX12B遺伝子におけるゲノム変異c.1654G>T p.Gly552Cys rs1201448391は、ミスセンス変異であり、タンパク質の552番目のアミノ酸であるグリシンがシステインに置換される結果をもたらします。この変異は、臨床的および遺伝的に多様性のある疾患である遺伝性魚鱗癬の文脈で同定されています。ALOX12B遺伝子は、表皮バリアの適切な機能に重要な12R-リポキシゲナーゼ酵素をコードしています。c.1654G>Tのような変異による酵素活性の欠損や障害は、異常なバリア機能を引き起こし、先天性魚鱗癬性紅皮症（CIE）を含む特定のタイプの魚鱗癬の特徴的な症状となります[1][2]。c.1654G>T変異は、アメリカ医療遺伝学会およびゲノム学会（ACMG）の基準に基づき、病原性/病原性の可能性が高いと分類されており、遺伝性魚鱗癬の診断におけるその臨床的重要性を強調しています。

全エクソーム解析（WES）は、このような変異を特定する上で強力なツールであり、正確な分子診断を可能にし、リスクのある家族に対する生殖計画、保因者スクリーニング、および出生前診断を促進します[1]。この変異の同定は、遺伝性魚鱗癬におけるWESの診断的価値を支持する証拠の蓄積に寄与し、影響を受けた個人およびその家族の管理やカウンセリングにおける遺伝子検査の重要性を浮き彫りにしています。
    
## References
- [1] Chegini M et al. (2023). "Whole exome sequencing identifies novel pathogenic variants in TGM1 and ALOX12B in patients with hereditary ichthyosis." Archives of dermatological research, 316(1) [PubMed](https://pubmed.ncbi.nlm.nih.gov/38060040/)
- [2] Kotoe Mae et al. (2022). "Novel homozygous missense mutation c.1654G>T in the ALOX12B gene causing congenital ichthyosiform erythroderma" The Journal of Dermatology, 50 [PubMed](https://pubmed.ncbi.nlm.nih.gov/36258281/)
- [3] Iorio F et al. (2016). "A Landscape of Pharmacogenomic Interactions in Cancer." Cell, 166(3) [SUPP] [PubMed](https://pubmed.ncbi.nlm.nih.gov/27397505/)
- [4] Triki M et al. (2020). "mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis." Cell reports, 31(12) [SUPP] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32579932/)

    
## ClinVar Submissions

    